The Journal of Clinical Psychiatry

Page 196

More JCP Articles

Article

Psychiatric Comorbidity in Hospitalized Adolescents With Borderline Personality Disorder

May 15, 2014

Carolyn Ha , Jessica C. Balderas , Mary C. Zanarini , et al

Book Review

Schizo-Obsessive Disorder

May 15, 2014

Peter F. Buckley

Commentary

Update on Best Practices for Managing Bipolar Depression

May 15, 2014

Gary S. Sachs , Terence A. Ketter

Article

The Youngest Children in Each School Cohort Are Overrepresented in Referrals to Mental Health Services

May 15, 2014

Shipra Berg , Erlend Berg

Educational Activity

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

May 15, 2014

Paul E. Keck, Jr.

Educational Activity

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

May 15, 2014

Jennifer G. Wells

Article

Magnetic Stimulation for Depression

May 15, 2014

Read a study evaluating the efficacy of repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder (MDD).

Bradley N. Gaynes , Stacey W. Lloyd , Linda Lux , et al

Original Research

Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter?

May 13, 2014

Neeltje M. Batelaan , Didi Rhebergen , Philip Spinhoven , et al

Original Research

Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

May 13, 2014

Michelle Magid , Jason S. Reichenberg , Poppy E. Poth , et al

Original Research

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

April 29, 2014

Mark Zimmerman , Iwona Chelminski , Diane Young , et al

Article

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer’s Disease Treatments in Presenilin 1 E280A Mutation Carriers

April 15, 2014

Napatkamon Ayutyanont , Jessica B. S. Langbaum , Suzanne B. Hendrix , et al

Article

Attention-Deficit/Hyperactivity Disorder Symptom Expression: A Comparison of Individual Age at Onset Using Item Response Theory

April 15, 2014

Hugo Peyre , Nicolas Hoertel , Samuele Cortese , et al

« 1 … 194 195 196 197 198 … 754 »

Psychiatric Comorbidity in Hospitalized Adolescents With Borderline Personality Disorder

Schizo-Obsessive Disorder

Update on Best Practices for Managing Bipolar Depression

The Youngest Children in Each School Cohort Are Overrepresented in Referrals to Mental Health Services

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

Magnetic Stimulation for Depression

Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter?

Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer’s Disease Treatments in Presenilin 1 E280A Mutation Carriers

Attention-Deficit/Hyperactivity Disorder Symptom Expression: A Comparison of Individual Age at Onset Using Item Response Theory

ELSEWHERE:

FOLLOW US:

More JCP Articles

Psychiatric Comorbidity in Hospitalized Adolescents With Borderline Personality Disorder

Schizo-Obsessive Disorder

Update on Best Practices for Managing Bipolar Depression

The Youngest Children in Each School Cohort Are Overrepresented in Referrals to Mental Health Services

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

Magnetic Stimulation for Depression

Two-Year Course Trajectories of Anxiety Disorders: Do DSM Classifications Matter?

Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study

A Clinically Useful Self-Report Measure of the DSM-5 Anxious Distress Specifier for Major Depressive Disorder

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer’s Disease Treatments in Presenilin 1 E280A Mutation Carriers

Attention-Deficit/Hyperactivity Disorder Symptom Expression: A Comparison of Individual Age at Onset Using Item Response Theory

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles